HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (N- (phenyl)butyryl- L- prolyl)pyrrolidine

inhibits prolyl endopeptidase; structure given in first source

Also Known As:

SUAM 1221; SUAM-1221

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrroles: 369
      - N-(N-(phenyl)butyryl-L-prolyl)pyrrolidine: 1

Experts

1.	Baumert, Marcel E: 1 article (12/2020)
2.	Grela, Karol: 1 article (12/2020)
3.	Kajetanowicz, Anna: 1 article (12/2020)
4.	Krzesiński, Paweł: 1 article (12/2020)
5.	Nienałtowski, Tomasz: 1 article (12/2020)
6.	Pawłowska, Jolanta: 1 article (12/2020)
7.	Skoczeń, Aleksandra: 1 article (12/2020)
8.	Suska-Kauf, Ewa: 1 article (12/2020)

Related Diseases

1.	Alzheimer Disease (Alzheimer's Disease) 12/14/2020 - "To place this solvent in a context of pharmaceutical R + D, larger-scale syntheses of SUAM 1221, a prolyl endopeptidase inhibitor with potential application in Alzheimer disease treatment, and a derivative of sildenafil, an analogue of the popular Viagra drug, were executed. "

Related Drugs and Biologics

1.	Solvents
2.	Prolyl Oligopeptidases
3.	Sildenafil Citrate (Viagra)